An Extension Study of TS-152 in Subjects with Rheumatoid Arthritis
An Extension Study of TS-152 in Subjects with Rheumatoid Arthritis
Rheumatoid Arthritis
Intervention name : ozoralizumab INN of the intervention : ozoralizumab Dosage And administration of the intervention : Subcutaneous injection of TS-152 30mg or TS-152 80mg every 4 weeks Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Intervention name : ozoralizumab INN of the intervention : ozoralizumab Dosage And administration of t ...
A Phase III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Without Methotrexate (MTX) Therapy A Phase III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Without Methotrexate ( ...
A Phase III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Without Methotrexate (MTX) Therapy A Phase III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Without Methotrexate ( ...
Rheumatoid Arthritis (RA)
Intervention name : TS-152 INN of the intervention : ozoralizumab Dosage And administration of the intervention : Subcutaneous injection every 4 weeks Control intervention name : - INN of the control intervention : - Dosage And administration of the control intervention : - Intervention name : TS-152 INN of the intervention : ozoralizumab Dosage And administration of the int ...
A Phase II/III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response to Methotrexate (MTX) Therapy A Phase II/III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Who Have Had an Ina ...
A Phase II/III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response to Methotrexate (MTX) Therapy A Phase II/III Study of TS-152 in Patients with Active Rheumatoid Arthritis (RA) Who Have Had an Ina ...
Rheumatoid Arthritis (RA)
Intervention name : TS-152 INN of the intervention : ozoralizumab Dosage And administration of the intervention : Subcutaneous injection every 4 weeks Control intervention name : Placebo INN of the control intervention : Placebo Dosage And administration of the control intervention : Usage: Subcutaneous injection every 4 weeks, Dosage: No active ingredients contain Intervention name : TS-152 INN of the intervention : ozoralizumab Dosage And administration of the int ...